Biosimilar Newsletter Archive
-
05.11.25 -- Embracing Outsourcing Quality Management In BioPharm
5/11/2025
05/11/25 Biosimilar Development Newsletter
-
05.08.25 -- Embracing Outsourcing Quality Management In BioPharm
5/8/2025
05/08/25 Biosimilar Development Newsletter
-
05.01.25 -- 3 Strategies For mAb Manufacturing: How Do You Choose?
5/1/2025
05/01/25 Biosimilar Development Newsletter
-
04.24.25 -- Intensifying Downstream Processing With Magnetic Separation
4/24/2025
04/24/25 Biosimilar Development Newsletter
-
04.17.25 -- AI Performance Management In Biologic And Drug Development
4/17/2025
04/17/25 Biosimilar Development Newsletter
-
04.10.25 -- U.S. Biosimilars Surge: Clinical Trials, Regulatory Shifts, And The Path To Dominance
4/10/2025
04/10/25 Biosimilar Development Newsletter
-
04.03.25 -- Optimize Downstream Separation With Tagless Proteins
4/3/2025
04/03/25 Biosimilar Development Newsletter
-
03.27.25 -- Challenges & Opportunities Of Outsourcing Biopharma Development
3/27/2025
03/27/25 Biosimilar Development Newsletter
-
03.26.25 -- De-Risk The Transfer of Process and Product Knowledge With an Experienced CDMO
3/26/2025
03/26/25 Biosimilar Development Newsletter
-
03.20.25 -- Discover How To Optimize Productivity In Your mAb Capture
3/20/2025
03/20/25 Biosimilar Development Newsletter